Abbott Nutrition

B · 2.90

Spinoff of Abbott (ABT) · Packaged Foods · Expected By end-2027

Similac, Ensure, PediaSure, Pedialyte and Glucerna, ~$8.5B of sales, spun tax-free by end-2027 under insider CEO Daniel Salvadori; debt and margins not yet disclosed

Snapshot Across Reports

Oct 30, 2026
StatusUpcoming
Investment GradeB (2.90)
Revenue~$8.5B
Expected DateBy end-2027

⚠ Auto-generated profile — not editorially reviewed.

This summary is compiled automatically from our tracked report data. A reviewed in-depth analysis is planned. For further detail ▸ read the Oct 30, 2026 report.